Revenue Breakdown
Composition ()
No data
Revenue Streams
Koninklijke Philips NV (PHG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Diagnosis & Treatment, accounting for 48.0% of total sales, equivalent to $2.36B. Other significant revenue streams include Connected Care and Personal Health. Understanding this composition is critical for investors evaluating how PHG navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Koninklijke Philips NV maintains a gross margin of 44.40%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.51%, while the net margin is 4.37%. These profitability ratios, combined with a Return on Equity (ROE) of 1.65%, provide a clear picture of how effectively PHG converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, PHG competes directly with industry leaders such as WAT and ILMN. With a market capitalization of $27.62B, it holds a leading position in the sector. When comparing efficiency, PHG's gross margin of 44.40% stands against WAT's 57.51% and ILMN's 67.62%. Such benchmarking helps identify whether Koninklijke Philips NV is trading at a premium or discount relative to its financial performance.
